IE812897L - Buspirone process - Google Patents
Buspirone processInfo
- Publication number
- IE812897L IE812897L IE812897A IE289781A IE812897L IE 812897 L IE812897 L IE 812897L IE 812897 A IE812897 A IE 812897A IE 289781 A IE289781 A IE 289781A IE 812897 L IE812897 L IE 812897L
- Authority
- IE
- Ireland
- Prior art keywords
- buspirone
- busipirone
- gb2089341a
- halopyrimidines
- chloropyrimidine
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 3
- QWCRAEMEVRGPNT-UHFFFAOYSA-N buspirone Chemical compound C1C(=O)N(CCCCN2CCN(CC2)C=2N=CC=CN=2)C(=O)CC21CCCC2 QWCRAEMEVRGPNT-UHFFFAOYSA-N 0.000 title 1
- 229960002495 buspirone Drugs 0.000 title 1
- UNCQVRBWJWWJBF-UHFFFAOYSA-N 2-chloropyrimidine Chemical compound ClC1=NC=CC=N1 UNCQVRBWJWWJBF-UHFFFAOYSA-N 0.000 abstract 2
- 150000005695 2-halopyrimidines Chemical class 0.000 abstract 1
- 230000029936 alkylation Effects 0.000 abstract 1
- 238000005804 alkylation reaction Methods 0.000 abstract 1
- 125000000246 pyrimidin-2-yl group Chemical group [H]C1=NC(*)=NC([H])=C1[H] 0.000 abstract 1
- 230000002285 radioactive effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/20—Spiro-condensed ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/30—Halogen atoms or nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/34—One oxygen atom
- C07D239/36—One oxygen atom as doubly bound oxygen atom or as unsubstituted hydroxy radical
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Busipirone of the formula <IMAGE> is prepared in a new process wherein the 2-pyrimidinyl component thereof is introduced in a final alkylation step involving 2-halopyrimidines. Radioactive labelled busipirone can be obtained according to the process by employing 2-chloro- pyrimidine-<14>C 2-chloropyrimidine- <15> N2.
[GB2089341A]
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US21521480A | 1980-12-11 | 1980-12-11 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IE812897L true IE812897L (en) | 1982-06-11 |
| IE51948B1 IE51948B1 (en) | 1987-04-29 |
Family
ID=22802113
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IE2897/81A IE51948B1 (en) | 1980-12-11 | 1981-12-10 | Buspirone process |
Country Status (18)
| Country | Link |
|---|---|
| JP (1) | JPS57122082A (en) |
| AT (1) | AT380686B (en) |
| AU (1) | AU528067B2 (en) |
| BE (1) | BE891446A (en) |
| CA (1) | CA1172255A (en) |
| CH (1) | CH647518A5 (en) |
| DE (1) | DE3149011A1 (en) |
| DK (1) | DK154560C (en) |
| FI (1) | FI73993C (en) |
| FR (1) | FR2496105B1 (en) |
| GB (1) | GB2089341B (en) |
| GR (1) | GR76331B (en) |
| IE (1) | IE51948B1 (en) |
| IT (1) | IT1172073B (en) |
| LU (1) | LU83833A1 (en) |
| NL (1) | NL8105529A (en) |
| SE (1) | SE444438B (en) |
| YU (1) | YU42432B (en) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HU212301B (en) * | 1989-04-28 | 1996-05-28 | Alkaloida Vegyeszeti Gyar | Process for producing buspirone |
| US5484788A (en) * | 1993-03-26 | 1996-01-16 | Beth Israel Hospital Association | Buspirone as a systemic immunosuppressant |
| US5631017A (en) * | 1993-03-26 | 1997-05-20 | Beth Israel Deaconess Medical Center, Inc. | Topical application of buspirone for treatment of pathological conditions associated with immune responses |
| KR950014099A (en) * | 1993-11-10 | 1995-06-15 | 장기하 | Method for preparing N- (2-pyrimidyl) piperazinyl butylamide |
| US5637314A (en) * | 1995-06-07 | 1997-06-10 | Beth Israel Deaconess Medical Center, Inc. | Topical and systemic application of buspirone or derivatives thereof for treating atopic dermatitis |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE759371A (en) * | 1969-11-24 | 1971-05-24 | Bristol Myers Co | HETEROCYCLICAL AZASPIRODECANEDIONES AND METHODS FOR THEIR PREPARATION |
| DE2341925A1 (en) * | 1973-08-20 | 1975-03-06 | Thomae Gmbh Dr K | 2,4, (opt.5-), 6-substd. pyriminidines as antithrombic agents - e.g. 6-methyl-5-nitro-2-piperazino-4-thiomorpolino-pyrimidine |
-
1981
- 1981-09-29 CA CA000386889A patent/CA1172255A/en not_active Expired
- 1981-10-05 AU AU76041/81A patent/AU528067B2/en not_active Expired
- 1981-10-09 YU YU2436/81A patent/YU42432B/en unknown
- 1981-10-27 GB GB8132370A patent/GB2089341B/en not_active Expired
- 1981-11-16 IT IT49718/81A patent/IT1172073B/en active
- 1981-11-27 GR GR66636A patent/GR76331B/el unknown
- 1981-12-08 NL NL8105529A patent/NL8105529A/en active Search and Examination
- 1981-12-08 FR FR8122916A patent/FR2496105B1/en not_active Expired
- 1981-12-08 CH CH7842/81A patent/CH647518A5/en not_active IP Right Cessation
- 1981-12-08 FI FI813937A patent/FI73993C/en not_active IP Right Cessation
- 1981-12-09 JP JP56197037A patent/JPS57122082A/en active Granted
- 1981-12-10 DE DE19813149011 patent/DE3149011A1/en active Granted
- 1981-12-10 DK DK548081A patent/DK154560C/en not_active IP Right Cessation
- 1981-12-10 AT AT0529581A patent/AT380686B/en not_active IP Right Cessation
- 1981-12-10 IE IE2897/81A patent/IE51948B1/en not_active IP Right Cessation
- 1981-12-11 BE BE0/206810A patent/BE891446A/en not_active IP Right Cessation
- 1981-12-11 SE SE8107446A patent/SE444438B/en not_active IP Right Cessation
- 1981-12-11 LU LU83833A patent/LU83833A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| LU83833A1 (en) | 1982-07-07 |
| AU528067B2 (en) | 1983-04-14 |
| DK154560C (en) | 1989-04-17 |
| FR2496105B1 (en) | 1985-12-13 |
| IT1172073B (en) | 1987-06-18 |
| FI73993C (en) | 1987-12-10 |
| BE891446A (en) | 1982-06-11 |
| GB2089341B (en) | 1984-09-19 |
| FI813937L (en) | 1982-06-12 |
| DK548081A (en) | 1982-06-12 |
| JPS57122082A (en) | 1982-07-29 |
| NL8105529A (en) | 1982-07-01 |
| DK154560B (en) | 1988-11-28 |
| YU243681A (en) | 1984-02-29 |
| GR76331B (en) | 1984-08-04 |
| AT380686B (en) | 1986-06-25 |
| JPH0113476B2 (en) | 1989-03-06 |
| IT8149718A0 (en) | 1981-11-16 |
| YU42432B (en) | 1988-08-31 |
| AU7604181A (en) | 1982-07-15 |
| SE8107446L (en) | 1982-06-12 |
| DE3149011A1 (en) | 1982-07-15 |
| FR2496105A1 (en) | 1982-06-18 |
| CH647518A5 (en) | 1985-01-31 |
| ATA529581A (en) | 1985-11-15 |
| IE51948B1 (en) | 1987-04-29 |
| DE3149011C2 (en) | 1988-08-25 |
| CA1172255A (en) | 1984-08-07 |
| SE444438B (en) | 1986-04-14 |
| GB2089341A (en) | 1982-06-23 |
| FI73993B (en) | 1987-08-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB2015018B (en) | Process for the preparation of concentrated solutions of dyestuffs and of brighteners | |
| IE781416L (en) | Carrier bound immunoglobulin | |
| IE812897L (en) | Buspirone process | |
| IE850867L (en) | Penicillins and azetidinones - stereocontrolled process. | |
| JPS52106244A (en) | Program module control system | |
| IE830790L (en) | Process for the production of an iron-selenium trace element¹solution | |
| AU514173B2 (en) | Preliminary reaction for assays involving nad(p)h formation | |
| PH17879A (en) | Process for converting 6,6-disubstituted penicillanic acid derivatives to the 6-beta-congeners | |
| UA19160A (en) | A process for preparation of alkyl anilinofumarate | |
| ES8701517A1 (en) | Method of solidifying waste slurries containing high concentrations of boric acid. | |
| JPS5318655A (en) | Chlorine-containing resin composition | |
| ES8406514A1 (en) | Process for preparating cationic latices. | |
| JPS57144287A (en) | Cyclopentabenzofuran derivative | |
| JPS5428386A (en) | Production of silane-modified polyolefin | |
| EP0034721A3 (en) | Polypeptide and its production and use | |
| JPS5242837A (en) | Synthetic process for coenzyme q group compounds | |
| ES8603476A1 (en) | Process for the preparation of substituted 2-imino-3,4,6,7-tetrahydro-4H-pyrimido[6,1-a]isoquinolin-4-ones | |
| GB1475482A (en) | Process for the preparation of pyroolidone-2 | |
| JPS57118570A (en) | Novel 3-phenyl-4-quinazolone derivative | |
| JPS5226753A (en) | Method for fabricating sludge modifier | |
| JPS51147500A (en) | Method of producing alkali silicate solution with high molar ratio | |
| JPS5479269A (en) | Preparation of optically active 5-oxo-2-pyrrolidinecarboxy anilide | |
| JPS5730317A (en) | Method of producing chip type solid electrolyte condenser | |
| JPS53132552A (en) | Preparation of 1,5-dinitroanthraquinone | |
| MA18595A1 (en) | PROCESS FOR THE FORMATION OF ALCOHOLIDES OF RYE ERGOT |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK9A | Patent expired |